Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Topical Advisory Panel
Click here to see the Section Topical Advisory Panel of "Viral Immunology, Vaccines, and Antivirals".
Special Issues
Following special issues within this section are currently open for submissions:
- Interferons in Viral Infections (Deadline: 30 June 2023)
- Host Cell–Virus Interaction 2.0 (Deadline: 30 June 2023)
- Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation (Deadline: 30 June 2023)
- Ways to Eliminate Viral Hepatitis as a Global Health Threat 2.0 (Deadline: 30 June 2023)
- Antiviral Molecular Mechanisms (Deadline: 1 July 2023)
- African Swine Fever Virus: Infection and Immunity (Deadline: 1 July 2023)
- Antibody-Based Therapeutics and Diagnostics for Viral Diseases (Deadline: 15 July 2023)
- HIV Elimination as the Goal by 2030 (Deadline: 20 July 2023)
- Recent Advances in the Fight against Respiratory Viruses (Deadline: 31 July 2023)
- Antiviral Treatment for Cytomegalovirus Diseases (Deadline: 31 July 2023)
- Vaccines and Antivirals in Pregnancy (Deadline: 31 July 2023)
- Biologics for Emerging and Reemerging Viral Infections (Deadline: 31 July 2023)
- Innovative Inhibitors against Viral Targets (Deadline: 31 July 2023)
- Viral-Induced Inflammation (Deadline: 31 August 2023)
- Novel Antiviral Targets against Emerging Viruses (Deadline: 31 August 2023)
- Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation (Deadline: 31 August 2023)
- Therapeutic Antibodies against Virus Infection (Deadline: 31 August 2023)
- Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection (Deadline: 31 August 2023)
- HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence 2.0 (Deadline: 31 August 2023)
- DNA Vaccines 2022 (Deadline: 1 September 2023)
- T Cells in Viral Infections Volume 2 (Deadline: 15 September 2023)
- Virus-Like Particle Vaccines 2023 (Deadline: 15 September 2023)
- SARS-CoV-2: Vaccine Design and Host Immunity (Deadline: 15 September 2023)
- Medicinal Chemistry Strategies for the Discovery of Novel Antiviral Agents (Deadline: 30 September 2023)
- Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents (Deadline: 30 September 2023)
- Immune Modulating Drugs in Viral Infections (Deadline: 30 September 2023)
- Control of Viral Epidemics through Vaccination (Deadline: 30 September 2023)
- Animal Coronaviruses: Infection, Prevention, and Antivirals (Deadline: 30 September 2023)
- Diagnostics, Antiviral Therapy and Vaccination against Orthopoxvirus Infections (Deadline: 15 October 2023)
- Regulation of Viral Replication and Cellular Antiviral Mechanisms by Components of SWI/SNF Complex (Deadline: 15 October 2023)
- Roles of Macrophages in Viral Infections (Deadline: 31 October 2023)
- Novel Viral Vectors for Gene Therapy 2023 (Deadline: 31 October 2023)
- Broad-Spectrum Antivirals and Interaction with Viruses (Deadline: 31 October 2023)
- Chemokines and Chemokine Receptors in Viral Infection 2023 (Deadline: 31 October 2023)
- Interferon-Induced Transmembrane Proteins at the Intersection of Virus Infection and Immunity (Deadline: 31 October 2023)
- Rabies Virus: Treatment and Prevention (Deadline: 31 October 2023)
- Current ART, Virologic Failure and Implications for HIV Drug Resistance (Deadline: 31 October 2023)
- STING-Mediated Antiviral Activity and Viral Evasion (Deadline: 30 November 2023)
- Pharmacology of Antivirals Targeting Metabolism and Immunity (Deadline: 30 November 2023)
- Advances and Novel Concepts in Herpesvirus Vaccines (Deadline: 30 November 2023)
- Regulation of the Virus Lifecycle by Cellular RNA-Binding Proteins (Deadline: 30 November 2023)
- Viral Entry Inhibitors 2023 (Deadline: 30 November 2023)
- Vaccines and Treatments for Viral Hemorrhagic Fevers (Deadline: 10 December 2023)
- Integrase Inhibitors 2023 (Deadline: 15 December 2023)
- Vaccines against Enveloped RNA Viruses (Deadline: 15 December 2023)
- Novel and Repurposed Antiviral Agents (Deadline: 16 December 2023)
- Antibody Response to Dengue, Zika and Other Flaviviruses (Deadline: 20 December 2023)
- Innate and Adaptive Immunity to Cutaneous Virus Infection (Deadline: 30 December 2023)
- Broadly Protective Anti-viral Vaccines (Deadline: 31 December 2023)
- Antivirals against Arboviruses (Deadline: 31 December 2023)
- Universal Influenza Vaccines for Humans and Animals (Deadline: 31 December 2023)
- RNA Viruses and Antibody Response 2nd Edition (Deadline: 31 January 2024)
- Innate Sensing and Restriction of Retroviruses (Deadline: 31 January 2024)
